Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Browsing Tag

stock

37 posts
NNovartis
Novartis Bolsters Immunology Pipeline With Excellergy Deal - March 27, 2026
Read More

Novartis Q1 Earnings & Revenues Miss Estimates, Stock Down – April 28, 2026

  • 2026-04-28
Key Takeaways Novartis’ Q1 EPS and revenues missed estimates, with declines caused by lower net income and sales.NVS’…
NNovartis
Novartis Bolsters Immunology Pipeline With Excellergy Deal - March 27, 2026
Read More

Novartis Q1 Earnings & Revenues Miss Estimates, Stock Down – April 28, 2026

  • 2026-04-28
Key Takeaways Novartis’ Q1 EPS and revenues missed estimates, with declines caused by lower net income and sales.NVS’…
RRoche
Roche Highlights Gazyva Progress, Reports Data on Enspryng, MS Drug - April 22, 2026
Read More

Roche Highlights Gazyva Progress, Reports Data on Enspryng, MS Drug – April 22, 2026

  • 2026-04-22
Key Takeaways Roches FDA filing for Gazyva in lupus follows phase III data showing 76.7% response vs 53.5%…
UUBS
TSLA's 5-Day Win Streak: AI5 Chip, Terafab & UBS Boost - Is it a Buy? - April 16, 2026
Read More

TSLA’s 5-Day Win Streak: AI5 Chip, Terafab & UBS Boost – Is it a Buy? – April 16, 2026

  • 2026-04-16
Key Takeaways TSLA stock rose over 7% yesterday, marking a 5-day rally as AI5 chip reached tape-out stage…
ZZürich
Is its premiumization strategy strong enough to unlock new up
Read More

Why This Swiss Airport Stock Suddenly Has Everyone Talking

  • 2026-04-16
Switzerland’s main airport isn’t just for layovers anymore. Flughafen Zürich AG just turned into a sleeper stock story,…
UUBS
Ford Stock Rises on UBS Upgrade and 2027 EPS Outlook | 2026 Analysis - News and Statistics
Read More

Ford Stock Rises on UBS Upgrade and 2027 EPS Outlook | 2026 Analysis – News and Statistics

  • 2026-04-15
Apr 15, 2026 Ford Motor Company shares experienced a notable increase in value following an analyst rating change,…
UUBS
UBS Warns Investors That 5 Risks Still Loom for Markets After the US-Iran Ceasefire
Read More

UBS Warns Investors That 5 Risks Still Loom for Markets After the US-Iran Ceasefire

  • 2026-04-08
Investors were jubilant on Wednesday following news that the US, Israel, and Iran had agreed to a two-week…
RRoche
Roche Holding AG (ROP.SW) stock price, news, quote and history
Read More

Roche Holding Ltd (RHHBY) Stock Forecasts

  • 2026-04-06
Summary Roche Holding AG operates through two segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment focuses on oncology, immunology,…
NNestlé
A Defensive Stock Under Pressure
Read More

A Defensive Stock Under Pressure

  • 2026-04-01
Nestlé, Shares 02.04.2026 – 00:47:44 | boerse-global.de Nestlé shares fall as retail giants’ market…
UUBS
UBS Group to Add 3,000 Jobs in India Amid Credit Suisse Integration - February 12, 2026
Read More

UBS Stock Rallies 6.5% on Signal of Softer Swiss Capital Requirements – April 1, 2026

  • 2026-04-01
Key Takeaways UBS shares jumped 6.5% after reports that Swiss lawmakers may soften stricter capital rules.Proposed rules had…
NNovartis
Novartis Bolsters Immunology Pipeline With Excellergy Deal - March 27, 2026
Read More

Novartis Bolsters Immunology Pipeline With Excellergy Deal – March 27, 2026

  • 2026-03-27
Key Takeaways Novartis to acquire Excellergy for up to $2B, adding Exl-111 to expand its IgE-focused pipeline.NVS strengthens…
VVitol
Venture Global Expands LNG Portfolio, Signs New Agreement With Vitol - March 24, 2026
Read More

Venture Global Expands LNG Portfolio, Signs New Agreement With Vitol – March 24, 2026

  • 2026-03-25
Key Takeaways Venture Global signed a 5-year deal to supply 1.5 MTPA LNG to Vitol starting in 2026.VG…
Switzerland
www.europesays.com